Protalix BioTherapeutics, Inc. (PLX) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 86.36M | 66.67M | 66.5M | 65.48M | 60.51M | 60.08M | 47.85M | 77.37M | 75.4M | 69.93M | 72.62M | 73.58M |
| Cash & Short-Term Investments | 51.79M | 30.27M | 29.37M | 33.4M | 34.74M | 34.83M | 27.41M | 45.03M | 48.49M | 44.56M | 40.98M | 48.18M |
| Cash Only | 41.71M | 14.68M | 13.65M | 17.89M | 19.46M | 19.76M | 27.41M | 23.4M | 27.21M | 23.63M | 20.41M | 48.18M |
| Short-Term Investments | 10.08M | 15.59M | 15.72M | 15.5M | 15.29M | 15.07M | 0 | 21.63M | 21.28M | 20.93M | 20.57M | 0 |
| Accounts Receivable | 2.94M | 8.84M | 14.43M | 9.44M | 4.67M | 2.91M | 2.19M | 10.13M | 3.76M | 5.27M | 8.94M | 4.05M |
| Days Sales Outstanding | 15.71 | 117.32 | 61.51 | 41.02 | 33.75 | 12.89 | 31.56 | 46.89 | 109.63 | 62.32 | 57.73 | 6.94 |
| Inventory | 30.47M | 25.73M | 21.25M | 21.13M | 19.51M | 21.24M | 17.2M | 20.72M | 22.35M | 19.05M | 21.58M | 19.64M |
| Days Inventory Outstanding | 612.83 | 467.91 | 234.23 | 314.99 | 224.17 | 455.05 | 208.27 | 207.22 | 723.79 | 211.03 | 387.5 | 295.57 |
| Other Current Assets | 1.15M | 1.44M | 1.45M | 1.51M | 1.59M | 596K | 1.05M | 1.49M | 812K | 611K | 1.13M | 1.71M |
| Total Non-Current Assets | 15.98M | 15.67M | 15.76M | 13M | 13.38M | 13.34M | 13.71M | 14.17M | 14.42M | 14.5M | 14.95M | 14.84M |
| Property, Plant & Equipment | 12.95M | 12.58M | 12.53M | 9.74M | 9.95M | 10.02M | 10.29M | 10.34M | 10.66M | 10.88M | 10.6M | 10.44M |
| Fixed Asset Turnover | 2.64x | 0.73x | 1.60x | 1.59x | 1.01x | 1.79x | 1.74x | 1.28x | 0.35x | 0.98x | 0.98x | 3.45x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 589K | 578K | 549K | 520K | 459K | 462K | 561K | 535K | 531K | 528K | 1.26M | 1.27M |
| Total Assets | 102.34M | 82.35M | 82.26M | 78.49M | 73.89M | 73.42M | 61.56M | 91.54M | 89.83M | 84.43M | 87.57M | 88.42M |
| Asset Turnover | 0.37x | 0.11x | 0.22x | 0.21x | 0.14x | 0.27x | 0.23x | 0.15x | 0.04x | 0.12x | 0.12x | 0.45x |
| Asset Growth % | 38.49% | 12.16% | 33.63% | -14.26% | -17.74% | -13.05% | -29.7% | 3.53% | 34.96% | 51.35% | 54.42% | 45.81% |
| Total Current Liabilities | 27.39M | 26.52M | 21.95M | 24.09M | 24.32M | 25.62M | 24.22M | 57.97M | 54.83M | 45.53M | 43.36M | 23.11M |
| Accounts Payable | 4.29M | 5.26M | 5.38M | 6.69M | 4.12M | 4.53M | 3.13M | 4.06M | 3.15M | 4.32M | 3.11M | 3.3M |
| Days Payables Outstanding | 104.07 | 105.9 | 66.67 | 83.79 | 47.61 | 90.77 | 39.54 | 34.69 | 130.55 | 38.61 | 60.34 | 62.23 |
| Short-Term Debt | 1.43M | 0 | 1.4M | 0 | 0 | 0 | 0 | 21.87M | 20.42M | 20.25M | 20.19M | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 2M | 0 | 0 | 12.7M | 11.04M | 0 | 0 | 0 |
| Other Current Liabilities | 14.76M | 2.31M | 15.17M | 2.21M | 1.88M | 1.81M | 1.71M | 4.6M | 1.7M | 1.6M | 4.29M | 3.44M |
| Current Ratio | 3.15x | 2.51x | 3.03x | 2.72x | 2.49x | 2.34x | 1.98x | 1.33x | 1.38x | 1.54x | 1.67x | 3.18x |
| Quick Ratio | 2.04x | 1.54x | 2.06x | 1.84x | 1.69x | 1.52x | 1.27x | 0.98x | 0.97x | 1.12x | 1.18x | 2.33x |
| Cash Conversion Cycle | 524.47 | 479.32 | 229.07 | 272.22 | 210.31 | 377.17 | 200.28 | 219.41 | 702.87 | 234.74 | 384.9 | 240.28 |
| Total Non-Current Liabilities | 7.72M | 7.6M | 7.41M | 4.49M | 4.36M | 4.58M | 4.91M | 4.99M | 5.21M | 5.33M | 5.96M | 26.31M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 20.13M |
| Capital Lease Obligations | 7.05M | 6.94M | 6.78M | 3.88M | 3.81M | 4.03M | 4.18M | 4.28M | 4.5M | 4.62M | 4.5M | 4.58M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 671K | 661K | 631K | 615K | 551K | 559K | 730K | 705K | 712K | 714K | 1.46M | 1.6M |
| Total Liabilities | 35.11M | 34.12M | 29.36M | 28.58M | 28.68M | 30.21M | 29.13M | 62.96M | 60.04M | 50.87M | 49.32M | 49.42M |
| Total Debt | 8.48M | 8.32M | 8.18M | 5.35M | 5.24M | 5.53M | 5.68M | 27.6M | 26.37M | 26.28M | 26.01M | 25.97M |
| Net Debt | -33.23M | -6.36M | -5.47M | -12.55M | -14.22M | -14.23M | -21.73M | 4.2M | -837K | 2.65M | 5.6M | -22.21M |
| Debt / Equity | 0.13x | 0.17x | 0.15x | 0.11x | 0.12x | 0.13x | 0.18x | 0.97x | 0.89x | 0.78x | 0.68x | 0.67x |
| Debt / EBITDA | 0.39x | - | 3.27x | 3.49x | - | 0.73x | 1.32x | - | - | - | - | 1.25x |
| Net Debt / EBITDA | -1.54x | - | -2.19x | -8.19x | - | -1.89x | -5.03x | - | - | - | - | -1.07x |
| Interest Coverage | 109.56x | -12.16x | 11.84x | 1.50x | -690.83x | 1220.33x | 13.85x | -5.19x | -11.14x | -7.30x | -2.74x | 16.06x |
| Total Equity | 67.23M | 48.23M | 52.91M | 49.9M | 45.21M | 43.21M | 32.44M | 28.58M | 29.79M | 33.57M | 38.25M | 39M |
| Equity Growth % | 48.71% | 11.62% | 63.11% | 74.6% | 51.78% | 28.72% | -15.19% | -26.72% | 2854.96% | 415.5% | 432.18% | 494.39% |
| Book Value per Share | 0.81 | 0.61 | 0.65 | 0.61 | 0.59 | 0.53 | 0.40 | 0.39 | 0.41 | 0.46 | 0.46 | 0.47 |
| Total Shareholders' Equity | 67.23M | 48.23M | 52.91M | 49.9M | 45.21M | 43.21M | 32.44M | 28.58M | 29.79M | 33.57M | 38.25M | 39M |
| Common Stock | 81K | 80K | 0 | 80K | 78K | 76K | 74K | 73K | 73K | 73K | 73K | 0 |
| Retained Earnings | -366.68M | -385M | 0 | -381.85M | -382.01M | -378.39M | -384.89M | -388.12M | -385.92M | -381.55M | -375.5M | 0 |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |